CSE: NARA / AQSE: NARA

PanGenomic Health Inc: Revolutionizing Wellness Through AI-Powered Healthcare

Thank you! Your form has been successfully submitted.

Who is PanGenomics?

Imagine if you had access to all of the known medical solutions and effects at your finger tips? How would this affect your health and wellness?

PanGenomics helps make this possible with Wellness Artificial Intelligence (AI).

PanGenomic Health Inc, provides the link between AI and personalized health. A beacon in this active, expanding and exciting sea of opportunity, by combining conventional medicine, holistic wellness, and next-level technology, PanGenomic provides solutions that are personalized and effective,

Market is Set To Explode

Telehealth market projected to hit $267.3 billion by 2026

Compound Annual Growth Rate (CAGR) of 23.4%.

Healthcare AI expected to reach $120.2 billion by 2028 - with a staggering 41.4% CAGR

74% of patients already open to using telehealth services and 76% prioritizing access to care over human interactions

DOWNLOAD OUR PLATFORM APPS:

HARNESS THE POWER OF HEALING INSIGHTS

Nara is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. With personalized insights and evidence-backed resources, users can take back control of their mental health.

Mindleap grants users access to great audio content and blogs, a mental health tracker, and access to professional services for mental well-being all through one convenient app.

MUJN: Clinical Platform for Health Practitioners

Pangenomics created MUJN to provide practitioners with access to data driven healthcare and wellness insights, from the palms of their hands.

MUJN Diagnostics offers a diagnostic system that tracks personalized health and wellness by combining point-of-care biomarker testing with symptom tracking. Our goal is to provide objective data for improved health and wellness through insights into health trends and actions for improvement.

Two Assessments in Market: Vitamin D Assessment and
BDNFBiomarker [Brain-Derived Neurotrophic Factor) Assessment

Data-Driven Decisions

Get access to real-time insights into your mental health and see potential risks before they occur.

Expert Support

Stay up-to-date with real-time notifications and alerts about potential risks or issues.

24/7 Access to Resources

Get personalized guidance to help you make the best decisions for your family's health and wellness.

PanGenomics Health In The News

MUJN Diagnostics Intros Point-of-Care Vitamin D Test for Dental Implant Industry

MUJN Diagnostic's expands Biomarker Assessment platform into dental implant industry: "Vitamin D can play significant role in success of a dental implant procedure. MUJN biomarker platform can help patients avoid potential dental implant failures caused by negative effects of Vitamin D deficiencies on osseointegration." Dec 6, 2023 News Release

PanGenomic Health's MUJN Diagnostics Announces First Sale of BDNF Biomarker Tests

MUJN Diagnostic's newest BDNF Biomarker AssessmentTest [Brain-Derived Neurotrophic Factor] for mental health and wellness. Changes in BDNF levels provide important treatment options for patients with brain health concerns such as Alzheimer's, Parkinson's, Huntington's and bipolar disease. Nov. 17, 2023 News Release


PanGenomic Health Subsidiary MUJN Launches Vitamin D Health Assessments

MUJN Diagnostics has commenced a Vitamin D health assessment service and launched a corporate website at mujn.ai Our first service provides Empower Health practitioners with rapid in-clinic access to patient Vitamin D assessments,”

July 7, 2023 News Release


Personalized Wellness Reimagined with AI Powered Healthcare

Unlock the power of personalized healthcare! PanGenomic Health provides AI-powered guidance to help you make informed decisions and take action to improve your health.

IMPORTANT NOTICE AND DISCLAIMER

This article is a paid advertisement. Traktor Beam Media Strategies Inc and its owners, managers, employees, and assigns (collectively “the Publisher”) is often paid by profiled companies or third parties to organize marketing campaigns, which include the creation and dissemination of these types of communications. In this case, in an effort to enhance public awareness of PanGenomic Health Inc. (“NARA”)and its securities, NARA has provided the Publisher with a budget of approximately $45,000.00 USD to cover the costs associated with creating and distribution of this communication. The Publisher may retain any excess sums after expenses as its compensation. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at anytime, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any potential investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher’s knowledge, as confirmed by NARA) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.

SHARE OWNERSHIP: The Publisher does not own any shares of any profiled company NARA and has no information concerning share ownership by others of in the profiled company NARA. The Publisher cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.

FORWARD LOOKING STATEMENTS: This publication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. The Publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the companies’ actual results of operations. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to NARA industry; (b) market opportunity; (c) NARA business plans and strategies; (d)services that NARA intends to offer; (e) NARA milestone projections and targets; (f) NARA expectations regarding receipt of approval for regulatory applications; (g) NARA intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) NARA expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute NARA business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) NARA ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) NARA ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) NARA ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19.Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of NARA to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) NARA operations could be adversely affected by possible future government legislation, policies and controls or by changes inapplicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact NARA business; (c) the volatility of global capital markets;(d) political instability and changes to the regulations governing NARA business operations (e) NARA may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.

INDEMNIFICATION/RELEASE OF LIABILITY: By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

INTELLECTUAL PROPERTY: Traktor Beam Media Strategies Inc. is the Publisher’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.

IMPORTANT NOTICE AND DISCLAIMER

This website is owned and hosted by Traktor Beam Media Strategies Inc. Articles appearing on this website should be considered paid advertisements. Traktor Beam Media Strategies Inc.. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The Website Host has not been compensated by any of the profiled companies. The Website Host’s compensation for articles appearing on this website is USD $500 per week while the advertisement campaign is active by Traktor Beam Media Strategies Inc as compensation to host the article profiling PanGenomic Health Inc..

SHARE OWNERSHIP: Website Host does not own any shares of any profiled PanGenomic Health Inc. and has no information concerning share ownership by others of any profiled companies and The Website Host cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.

NO SECURITIES OFFERED: The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of any PanGenomic Health Inc. or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the PanGenomic Health Inc.. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled PanGenomic Health Inc.’s SEC and/or other government filings. Investing in securities, particularly micro-cap securities, is speculative and carries a high degree of risk.

INDEMNIFICATION/RELEASE OF LIABILITY: By reading articles on this website, you acknowledge that you have read and understood this disclaimer, and further that to the greatest extent permitted under law, you release the Website Host, its affiliates, assigns and successors from any and all liability, damages, and injury from articles appearing on this website. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

LINKS TO THIRD PARTY WEBSITES: This website enables users to link to external websites not under the control of The Website Host. The Website Host has no control over the nature, content, and availability of those sites. The inclusion of any links is not intended as, and should not be construed as, a recommendation or endorsement of the content or views expressed on such external websites. The Website Host expressly disclaims any representation concerning the quality, safety, suitability, or reliability of any external websites and the content and materials contained in them. It is important for users to take necessary precautions, especially to ensure appropriate safety.

INTELLECTUAL PROPERTY: Traktor Beam Media Strategies Inc is the Website Host’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Website Host is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Website Host to any rights in any third-party trademarks.

FORWARD LOOKING INFORMATION: This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect expectations regarding PanGenomic Health Inc. future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation therefore other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to PanGenomic Health Inc. industry; (b) market opportunity; (c) PanGenomic Health Inc. business plans and strategies;(d) services that PanGenomic Health Inc. intends to offer; (e) PanGenomic Health Inc. milestone projections and targets; (f) PanGenomic Health Inc. expectations regarding receipt of approval for regulatory applications; (g) PanGenomic Health Inc. intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) PanGenomic Health Inc. expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management inflight of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute PanGenomic Health Inc. business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) PanGenomic Health Inc. ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) PanGenomic Health Inc. ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) PanGenomic Health Inc. ability to attract and retains skilled personnel; (g) political and regulatory stability; (h)the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i)changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of PanGenomic Health Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) PanGenomic Health Inc. operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact PanGenomic Health Inc. business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing PanGenomic Health Inc. business operations (e) PanGenomic Health Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.

HISTORICAL INFORMATION: Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of PanGenomic Health Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of PanGenomic Health Inc. or such entities and are not necessarily indicative of future performance of PanGenomic Health Inc. or such entities.